Blog
RSS FeedPosted by Michael Wonder on 11 Oct 2020
Can Trump really speed approval of COVID treatments?
10 October 2020 - In a five minute video posted to his Twitter account on Wednesday, President Trump stood in ...
Posted by Michael Wonder on 08 Oct 2020
Accounting for US public funding in drug development: how can we better balance access, affordability, and innovation?
8 October 2020 - US drug prices are the highest in the world and are continuing to rise, with an increasing ...
Posted by Michael Wonder on 26 Aug 2020
Developing safe and effective COVID vaccines — Operation Warp speed’s strategy and approach
26 August 2020 - Announced on May 15, Operation Warp Speed— a partnership of the Department of Health and Human ...
Posted by Michael Wonder on 25 Aug 2020
As COVID-19 pressures mount, political newcomer Stephen Hahn struggles to protect an FDA under siege
24 August 2020 - Stephen Hahn, a political novice who moved here in December to take over the FDA, has ...
Posted by Michael Wonder on 17 Jun 2020
An ‘America first’ pharma supply chain sounds good. But it won’t work.
17 June 2020 - With a stroke of the president’s Executive Order pen, the Trump administration awarded a $354 million, ...
Posted by Michael Wonder on 04 Jun 2020
The Lancet, New England Journal retract COVID-19 studies, including one that raised safety concerns about malaria drugs
4 June 2020 - The Lancet, one of the world’s top medical journals, on Thursday retracted an influential study that ...
Posted by Michael Wonder on 03 Jun 2020
The CDC waited its entire existence for this moment. What went wrong?
3 June 2020 - Americans returning from China landed at U.S. airports by the thousands in early February, potential carriers ...
Posted by Michael Wonder on 28 May 2020
‘Vaccine nationalism’: a new dynamic in the race to quash coronavirus
27 May 2020 - International pursuit for a shot is shifting into a contest of which world power can immunise its ...
Posted by Michael Wonder on 28 May 2020
Modelling epidemics with compartmental models
27 May 2020 - During epidemics, there is a critical need to understand both the likely number of infections and their ...
Posted by Michael Wonder on 25 May 2020
How the world’s premier public health agency was handcuffed
23 May 2020 - The CDC has been absent with leave during the spread of COVID-19. ...
Posted by Michael Wonder on 21 May 2020
What to expect when a coronavirus vaccine finally arrives
20 May 2020 - Sobering lessons from the history of the polio vaccine. ...
Posted by Michael Wonder on 10 May 2020
COVID-19 raises questions about the value of personalised medicine
8 May 2020 - A group of medical dissenters argues that tailoring treatment to the genetic profiles of individuals, a longstanding ...
Posted by Michael Wonder on 06 May 2020
Will Gilead price its coronavirus drug for public good or company profit?
7 May 2020 - Gilead faces a new dilemma in deciding how much it should profit from the only treatment so ...
Posted by Michael Wonder on 06 May 2020
Remdesivir helps coronavirus patients — but at what cost?
6 May 2020 - Drug maker Gilead is known for creating breakthrough drugs and selling them at a premium. ...
Posted by Michael Wonder on 04 May 2020
How remdesivir, new hope for COVID-19 patients, was resurrected
4 May 2020 - The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on ...